170 related articles for article (PubMed ID: 37647111)
1. m6A-Mediated Biogenesis of circDDIT4 Inhibits Prostate Cancer Progression by Sequestrating ELAVL1/HuR.
Kong Z; Lu Y; Yang Y; Chang K; Lin Y; Huang Y; Wang C; Zhang L; Xu W; Zhao S; Li Y
Mol Cancer Res; 2023 Dec; 21(12):1342-1355. PubMed ID: 37647111
[TBL] [Abstract][Full Text] [Related]
2. METTL3 and ALKBH5 oppositely regulate m
Song H; Feng X; Zhang H; Luo Y; Huang J; Lin M; Jin J; Ding X; Wu S; Huang H; Yu T; Zhang M; Hong H; Yao S; Zhao Y; Zhang Z
Autophagy; 2019 Aug; 15(8):1419-1437. PubMed ID: 30870073
[TBL] [Abstract][Full Text] [Related]
3. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G
Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270
[TBL] [Abstract][Full Text] [Related]
4. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
5. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
6. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
[TBL] [Abstract][Full Text] [Related]
7. N6-methyladenosine modification in trophoblasts promotes circSETD2 expression, inhibits miR-181a-5p, and elevates MCL1 transcription to reduce apoptosis of trophoblasts.
Wang D; Guan H; Wang Y; Song G; Xia Y
Environ Toxicol; 2023 Feb; 38(2):422-435. PubMed ID: 36260529
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of m6A regulators prognostic value in prostate cancer.
Ji G; Huang C; He S; Gong Y; Song G; Li X; Zhou L
Aging (Albany NY); 2020 Jul; 12(14):14863-14884. PubMed ID: 32710725
[TBL] [Abstract][Full Text] [Related]
9. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
10. Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells.
Chen Y; Pan C; Wang X; Xu D; Ma Y; Hu J; Chen P; Xiang Z; Rao Q; Han X
Theranostics; 2021; 11(16):7640-7657. PubMed ID: 34335955
[No Abstract] [Full Text] [Related]
11. m6A-dependent up-regulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma.
Ling Z; Chen L; Zhao J
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32266933
[TBL] [Abstract][Full Text] [Related]
12. METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.
Wang D; Wang X; Huang B; Zhao Y; Tu W; Jin X; Shao Y; Zhu Y; Lu G
Andrologia; 2022 Aug; 54(7):1581-1591. PubMed ID: 35413135
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA circRHOBTB3 represses metastasis by regulating the HuR-mediated mRNA stability of PTBP1 in colorectal cancer.
Chen J; Wu Y; Luo X; Jin D; Zhou W; Ju Z; Wang D; Meng Q; Wang H; Fu X; Xu J; Song Z
Theranostics; 2021; 11(15):7507-7526. PubMed ID: 34158864
[No Abstract] [Full Text] [Related]
14. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
[TBL] [Abstract][Full Text] [Related]
15. m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer.
Petri BJ; Klinge CM
J Mol Endocrinol; 2023 Feb; 70(2):. PubMed ID: 36367225
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk among writers, readers, and erasers of m
Panneerdoss S; Eedunuri VK; Yadav P; Timilsina S; Rajamanickam S; Viswanadhapalli S; Abdelfattah N; Onyeagucha BC; Cui X; Lai Z; Mohammad TA; Gupta YK; Huang TH; Huang Y; Chen Y; Rao MK
Sci Adv; 2018 Oct; 4(10):eaar8263. PubMed ID: 30306128
[TBL] [Abstract][Full Text] [Related]
17. Glucose Is Involved in the Dynamic Regulation of m6A in Patients With Type 2 Diabetes.
Yang Y; Shen F; Huang W; Qin S; Huang JT; Sergi C; Yuan BF; Liu SM
J Clin Endocrinol Metab; 2019 Mar; 104(3):665-673. PubMed ID: 30137347
[TBL] [Abstract][Full Text] [Related]
18. Methyltransferase-like 3 promotes cervical cancer metastasis by enhancing cathepsin L mRNA stability in an N6-methyladenosine-dependent manner.
Liu P; Ju M; Zheng X; Jiang Y; Yu X; Pan B; Luo R; Jia W; Zheng M
Cancer Sci; 2023 Mar; 114(3):837-854. PubMed ID: 36382580
[TBL] [Abstract][Full Text] [Related]
19. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
20. M6A-modified circRBM33 promotes prostate cancer progression via PDHA1-mediated mitochondrial respiration regulation and presents a potential target for ARSI therapy.
Zhong C; Long Z; Yang T; Wang S; Zhong W; Hu F; Teoh JY; Lu J; Mao X
Int J Biol Sci; 2023; 19(5):1543-1563. PubMed ID: 37056926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]